Related Experiment Video

Updated: Aug 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell

G Agiostratidou1, A Derventzi, E S Gonos

  • 1National Hellenic Research Foundation, Institute of Biological Research and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.

In Vivo (Athens, Greece)
|November 7, 2001
PubMed

Insights

Cyclin-dependent kinase inhibitors (CDKIs) halt the proliferation of human osteosarcoma cells. This study demonstrates CDKIs

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Human somatic cells have limited divisions, while immortal cells evade growth regulation.
  • Cyclin-dependent kinase inhibitors (CDKIs) are key regulators of cellular senescence and cancer.
  • CDKIs are over-expressed in senescent cells and downregulated in many human cancers.

Purpose of the Study:

  • To investigate the impact of CDKIs on the proliferative capacity of human osteosarcoma cell lines.
  • To determine the role of specific CDKIs (p15INK4b, p16INK4a, p21CIP1/WAF1) in osteosarcoma cell growth.
  • To elucidate the molecular links between cellular mortality and immortality in the context of osteosarcoma.

Main Methods:

  • Transient expression of CDKIs (p15INK4b, p16INK4a, p21CIP1/WAF1) in KHOS cells.
  • DNA synthesis inhibition assays to assess cell cycle progression.
  • Stable transfection of p21CIP1/WAF1 and p16INK4a genes into KHOS and U2-OS osteosarcoma cell lines.

Main Results:

  • Transient expression of p15INK4b, p16INK4a, and p21CIP1/WAF1 induced growth arrest in KHOS cells, preventing S-phase entry.
  • Stable transfection of p21CIP1/WAF1 repressed the immortal phenotype in both KHOS and U2-OS cells.
  • Temporary over-expression of p16INK4a reversibly inhibited cell growth in osteosarcoma cell lines.

Conclusions:

  • CDKIs effectively mediate growth arrest in human osteosarcoma cell lines.
  • p21CIP1/WAF1 demonstrates a significant role in repressing the immortal phenotype of osteosarcoma cells.
  • The study provides evidence for molecular connections between cellular mortality and immortality regulated by CDKIs.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...